|
⚲
|
| Keyboard |
| Schneid Yair
✚
|
|
|---|---|
| CIK # | 0002008233 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0002008233] | |
| 4 | [0002008233] | |
| SC 13G | [0002008233] |
| Form 13D/13G Filer | Form 13D/13G Subject | Filed |
|---|---|---|
| Schneid Yair | Galera Therapeutics Inc | [2024-01-17] |
| Schneid Yair | Reshape Lifesciences Inc | [2024-01-17] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Schneid Yair | |
| Galera Therapeutics Inc | |
| Obalon Therapeutics Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Galera Therapeutics Inc GRTX
Common Stock
|
2024-02-08 | Buy | 150,000 | $0.17 | 25,500 |
|
Galera Therapeutics Inc GRTX
Common Stock
|
2024-02-07 | Buy | 150,000 | $0.17 | 25,500 |
|
Galera Therapeutics Inc GRTX
Common Stock
|
2024-02-07 | Buy | 25,000 | $0.17 | 4,250 |
|
Galera Therapeutics Inc GRTX
Common Stock
|
2024-02-06 | Buy | 25,000 | $0.20 | 5,000 |
|
Galera Therapeutics Inc GRTX
Common Stock
|
2024-02-05 | Buy | 97,402 | $0.18 | 17,532 |
|
Galera Therapeutics Inc GRTX
Common Stock
|
2024-01-30 | Buy | 335,000 | $0.18 | 60,300 |
|
Galera Therapeutics Inc GRTX
Common Stock
|
2024-01-29 | Buy | 150,000 | $0.18 | 27,000 |